Overview

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Status:
Unknown status

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Studying samples of blood in the laboratory from patients with breast cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue. PURPOSE: This research study is studying biomarkers associated with fatigue in patients with early-stage breast cancer treated with metformin or placebo on NCIC-CTG-MA.32.

Details

Lead Sponsor:

NSABP Foundation Inc

Collaborator:

National Cancer Institute (NCI)

Treatments:

Metformin